Announcements Trials
Browse Landscape

Status

Completed 3Terminated 1

Sponsor Class

OTHER 2INDUSTRY 1

Study Type

Interventional 23Observational 3

Sponsor

Cancer Type

Genitourinary 3

Conditions

Prostatic Neoplasms 2Castrate Refractory Metastatic Prostate Cancer (mCRPC) 1

Interventions

Surveys and Questionnaires 286Blood Specimen Collection 145Gene Expression Profiling 96Interviews as Topic 83Immunohistochemistry 78Polymerase Chain Reaction 64Surgical Procedures, Operative 62Magnetic Resonance Spectroscopy 58Microarray Analysis 55Flow Cytometry 53Radiotherapy 49Amplified Fragment Length Polymorphism Analysis 48Drug Therapy 46Observation 45Biopsy 42Reverse Transcriptase Polymerase Chain Reaction 39Bevacizumab 39Data Collection 35Sorafenib 29Psychiatric Rehabilitation 29Nivolumab 28palbociclib 26In Situ Hybridization, Fluorescence 26Rituximab 25Therapeutics 24Neoadjuvant Therapy 24Hepatectomy 24Docetaxel 24Colonoscopy 24Sunitinib 23

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
Completed × Observational × sipuleucel-T × Clear all
NCT02353715 2020-12-24

PEAX

Duke University

Completed
38 enrolled
Genitourinary

Prostatic Neoplasms

NCT01306890 2019-06-07

PROCEED

Dendreon

Completed
1,976 enrolled 20 charts
Genitourinary

Prostatic Neoplasms

NCT02232230 2019-01-09

A Multicenter Trial Enrolling Men With Advanced Prostate Cancer Who Are to Receive Combination Radiation and Sipuleucel-T

GenesisCare USA

Completed
20 enrolled
Genitourinary

Castrate Refractory Metastatic Prostate Cancer (mCRPC)

Data powered by HemOnc (CC BY 4.0) Colophon âš¡